When does the Alecensa (alectinib) patent expire?
The exact patent-expiry date for Alecensa depends on which patent family and which country (or region) you mean. Patent terms vary by jurisdiction, and manufacturers often hold multiple overlapping patents covering different claims (drug substance, formulations, manufacturing processes, or related methods).
What kinds of patents can affect Alecensa’s effective exclusivity?
Even when a “core” patent expires, exclusivity can still be extended by other patent types or regulatory exclusivities, such as:
- patents on additional claims (e.g., particular formulations or uses)
- process/manufacturing patents
- separate patents held by different entities in the same family
Because these protections expire on different schedules, the “effective” market exclusivity end date can be later than the earliest headline patent expiry.
Does patent expiry automatically mean generic Alecensa can launch?
No. A generic or biosimilar-style alternative would still need to address the relevant legal barriers in its jurisdiction, such as:
- other still-in-force patents listed in local regulatory patent lists
- patent litigation or settlements that can delay launch even after one patent expires
How to find the exact expiry date for your location
To determine the correct Alecensa patent expiry, you need:
1) the country/region (e.g., US vs EU vs UK vs Canada)
2) the specific patent(s) being considered (the listing tied to the drug authorization, not just one patent)
If you tell me the jurisdiction (and whether you mean the US FDA Orange Book or an EU/UK registry), I can narrow to the specific patent entries and their expiry dates based on that system.
If you mean “when does generics/biosimilars arrive?” (practical timeline)
The practical timeline is driven by the interaction of:
- patent expiry dates for the relevant listed patents
- any regulatory exclusivity windows
- ongoing litigation/settlements that block launch
So generics may be delayed past the first patent expiry date.
---
Sources
No sources were provided in your prompt. If you share the jurisdiction (e.g., US or EU) or the specific patent/publication numbers you’re looking at, I can give a precise expiry answer using those details.